Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C22H28N2O5S |
| Molecular Weight | 432.533 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@H](SC(C)=O)C(=O)N[C@H]1CC2=CC=CC=C2[C@H]3CCC[C@H](N3C1=O)C(O)=O
InChI
InChIKey=FXKFFTMLFPWYFH-RDGPPVDQSA-N
InChI=1S/C22H28N2O5S/c1-12(2)19(30-13(3)25)20(26)23-16-11-14-7-4-5-8-15(14)17-9-6-10-18(22(28)29)24(17)21(16)27/h4-5,7-8,12,16-19H,6,9-11H2,1-3H3,(H,23,26)(H,28,29)/t16-,17+,18-,19-/m0/s1
| Molecular Formula | C22H28N2O5S |
| Molecular Weight | 432.533 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ilepatril, previously known as AVE7688, an inhibitor of neutral endopeptidase and angiotensin-converting enzyme (ACE), was initially being developed for cardiac failure. Ilepatril was in phase IIb/III clinical trials for hypertension and in phase II trials for diabetic nephropathy, however, studies were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats. | 2012-02-29 |
|
| Role of the effect of inhibition of neutral endopeptidase on vascular and neural complications in streptozotocin-induced diabetic rats. | 2011-01-15 |
|
| Effect of Treatment of Sprague Dawley Rats with AVE7688, Enalapril, or Candoxatril on Diet-Induced Obesity. | 2011 |
|
| Vasopeptidase inhibition normalizes blood pressure and restores endothelial function in renovascular hypertension. | 2006 |
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00284128
oral administration (capsules)(2.5 or 10 or 35 or 50 mg ) once daily
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:42:32 GMT 2025
by
admin
on
Mon Mar 31 18:42:32 GMT 2025
|
| Record UNII |
5N1YAP5FCM
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C270
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB06604
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
5N1YAP5FCM
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
DTXSID7047356
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
9824131
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
300000034188
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
473289-62-2
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
C87731
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY | |||
|
8766
Created by
admin on Mon Mar 31 18:42:32 GMT 2025 , Edited by admin on Mon Mar 31 18:42:32 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |